Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. View on euronews ...
The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
How do different cancer subtypes arise? Do they originate from distinct cells, or from a single multipotent cell capable of ...
Women taking GLP-1 drugs 30 percent less likely to develop breast cancer, researchers say - About 42,140 women are expected ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
The incidence of the cancer has doubled over the past 25 years. But it's also a disease without a public profile, which means ...
Did you know that a simple genetic test called DNA testing is all that is needed to understand if you are at risk of ...
An artificial intelligence model from the Mayo Clinic detected early signs of possible pancreatic cancer on scans up to two years before patients were diagnosed.
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results